HER-2/NEU (HER2) peptide based vaccine with FLT3 ligand (FL) +/- GM-CSF as an adjuvant.

被引：0
|
作者：
Disis, ML
Rinn, K
Davis, D
Caron, D
Schiffman, K
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Immunex Corp, Seattle, WA USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1961
引用
收藏
页码：456A / 456A
页数：1
相关论文
共 50 条
  • [41] Biomarker correlation to clinical response in a phase II trial of the HER2 peptide vaccine (AE37+GM-CSF)
    Schneble, Erika
    Berry, John S.
    Vreeland, Timothy J.
    Trappey, Alfred F.
    Clifton, Guy T.
    Ponniah, Sathibalan
    Perez, Sonia
    Papamichail, Michael
    Peoples, George E.
    Mittendorf, Elizabeth A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (04) : E47 - E47
  • [42] A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
    Wiedermann, Ursula
    Wiltschke, C.
    Jasinska, J.
    Kundi, M.
    Zurbriggen, R.
    Garner-Spitzer, E.
    Bartsch, R.
    Steger, G.
    Pehamberger, H.
    Scheiner, O.
    Zielinski, C. C.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (03) : 673 - 683
  • [43] A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
    Ursula Wiedermann
    C. Wiltschke
    J. Jasinska
    M. Kundi
    R. Zurbriggen
    E. Garner-Spitzer
    R. Bartsch
    G. Steger
    H. Pehamberger
    O. Scheiner
    C. C. Zielinski
    Breast Cancer Research and Treatment, 2010, 119 : 673 - 683
  • [44] Evaluation of booster injections in maintaining peak immunity in a phase IIb study evaluating HER2/neu peptide GP2 (GLSI-100) versus GM-CSF alone after adjuvant trastuzumab in women with HER2-positive breast cancer.
    Patel, Snehal
    McWilliams, David
    Thompson, Jaye
    Patel, Mira
    Daugherty, F. Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (17)
  • [45] Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial
    Mittendorf, EA
    Storrer, C
    Shriver, C
    Ponniah, S
    Peoples, G
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 201 (03) : S79 - S79
  • [46] Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial
    Mittendorf, Elizabeth A.
    Storrer, Catherine E.
    Foley, Rebecca J.
    Harris, Katie
    Jama, Yusuf
    Shriver, Craig D.
    Ponniah, Sathibalan
    Peoples, George E.
    CANCER, 2006, 106 (11) : 2309 - 2317
  • [47] Correlation between Robust Local Reactions Prompting GM-CSF Dose Reduction to Clinical Response in a Phase II Trial of the GP2+GM-CSF HER2 Peptide Vaccine to Prevent Breast Cancer Recurrence
    Greene, Julia
    Schneble, Erika
    Richie, Laura
    Perez, Sonia A.
    Trappey, Alfred F.
    Berry, John S.
    Papamichail, Michael
    Clifton, Guy T.
    Mittendorf, Elizabeth A.
    Peoples, George E., Jr.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015, 221 (04) : S18 - S19
  • [48] Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine★
    Matthew T. Hueman
    Alexander Stojadinovic
    Catherine E. Storrer
    Rebecca J. Foley
    Jennifer M. Gurney
    Craig D. Shriver
    Sathibalan Ponniah
    George E. Peoples
    Breast Cancer Research and Treatment, 2006, 98 : 17 - 29
  • [49] Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine
    Hueman, Matthew T.
    Stojadinovic, Alexander
    Storrer, Catherine E.
    Foley, Rebecca J.
    Gurney, Jennifer M.
    Shriver, Craig D.
    Ponniah, Sathibalan
    Peoples, George E.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 98 (01) : 17 - 29
  • [50] Analysis of naive and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine
    Hueman, Matthew T.
    Stojadinovic, Alexander
    Storrer, Catherine E.
    Dehqanzada, Zia A.
    Gurney, Jennifer M.
    Shriver, Craig D.
    Ponniah, Sathibalan
    Peoples, George E.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (02) : 135 - 146
12345